AstraZeneca will seek regulatory approval for an antibody drug after a study showed it significantly reduces the risk of developing COVID-19 symptoms.
Breaking News & Events
AstraZeneca will seek regulatory approval for an antibody drug after a study showed it significantly reduces the risk of developing COVID-19 symptoms.